RAPS, Eucomed Partner to Provide Online Training to Regulatory Professionals Throughout Europe
The Regulatory Affairs Professionals Society (RAPS), the largest global organization for regulatory professionals in the healthcare product sector, and Eucomed, the European medical technology industry association, have joined together to provide high-quality online regulatory training to professionals throughout Europe.
The agreement will make courses and certificate programs from RAPS Online University available to Eucomed members at a 10% discount.
“We are very proud of the outstanding training our team has custom developed for regulatory and related professionals and is offered through RAPS Online University,” said RAPS Executive Director Sherry Keramidas, PhD, FASAE, CAE. “It is extremely gratifying that the leadership of a highly respected organization such as Eucomed also recognizes the value RAPS courses can offer its members.”
RAPS’ courses cover an array regulatory and business topics, from general knowledge to product- and region-specific subject matter. Regulatory professionals may take individual courses to address knowledge gaps or enhance understanding of specific areas, or they may opt to earn a certificate by completing customizable curricula of online courses.
RAPS, headquartered in the US with members and affiliates throughout the world, also recently signed an agreement with China’s State Food and Drug Administration to provide regulatory training resources, and has another training partnership in place with and the University of Shanghai for Science and Technology.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
